What is Alfie?
Alfie Health, now integrated with knownwell, focuses on precision metabolic health management via its proprietary ObesityRx platform. This AI-powered technology assists healthcare providers in developing effective care pathways for patients with metabolic conditions, particularly obesity. By leveraging data-driven strategies, Alfie aims to enhance patient care and promote sustainable metabolic health outcomes. The company's integration with knownwell signifies a strategic move to embed its advanced technological solutions within a broader evidence-based care model, enhancing the overall healthcare experience for individuals managing complex metabolic conditions.
How much funding has Alfie raised?
Alfie has raised a total of $2.1M across 1 funding round:
Other Financing Round
$2.1M
Other Financing Round (2023): $2.1M with participation from Phoenix Fund, Goodwater Capital, Nina Capital, and Y Combinator
Key Investors in Alfie
Phoenix Fund
Phoenix Fund, associated with the Phoenix Investment Club, is an organization that supports and invests in startups from the Harvard community, focusing on fostering entrepreneurship and innovation within the ecosystem.
Goodwater Capital
Goodwater Capital is a consumer tech investment firm that backs exceptional entrepreneurs, investing in innovative companies across financial services, retail, and healthcare with a global user base.
Y Combinator
Y Combinator is a renowned startup accelerator that provides seed funding and mentorship to early-stage companies, helping them grow and scale their businesses.
What's next for Alfie?
With the recent infusion of capital and its strategic acquisition by knownwell, Alfie is poised for significant expansion in the precision metabolic health sector. The company's focus on data-driven insights and AI-driven care pathways suggests a trajectory towards further technological development and broader market penetration. Future growth is likely to involve scaling the ObesityRx platform, enhancing its integration with knownwell's existing infrastructure, and potentially exploring new therapeutic areas within metabolic disease management. This strategic backing provides the necessary resources to accelerate innovation and solidify Alfie's position as a leader in personalized metabolic health solutions.
See full Alfie company page
